Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
The deal puts an end to Fubo’s ongoing lawsuit that sought to block Disney’s efforts to build Venu Sports with Fox and Warner Bros. Discovery.
Record earnings from Foxconn and some fresh tariff news highlight core themes likely to dominate headlines this year.
People who work on Wall Street face a more quotidian challenge starting this morning: getting there, thanks to New York’s congestion pricing.